Regulatory review models and approval timelines across African regulators – Chisha 2026
A new study involving CIRS compares regulatory review models, practices and marketing authorisation timelines across four African national medicines regulatory authorities (NMRAs): Ghana Food and Drugs Authority (Ghana FDA), [...]